Human and murine IL2 receptors differentially respond to the human-IL2 component of immunocytokines-Reference-Cited by-同舟云学术

Human and murine IL2 receptors differentially respond to the human-IL2 component of immunocytokines

Published:2018-05-07 Issue:6 Volume:8 Page:e1238538
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Perez Horta Zulmarie¹,Saseedhar Swetha¹^ORCID,Rakhmilevich Alexander L.¹,Carmichael Lakeesha²,Hank Jacquelyn A.¹,Boyden Margaret¹,Gillies Stephen D.³^ORCID,Sondel Paul M.¹⁴

Affiliation:

1. Department of Human Oncology, University of Wisconsin, Madison, WI, USA

2. Department of Biostatistics and Bioinformatics, University of Wisconsin, Madison, WI, USA

3. Provenance Biopharmaceuticals, Carlisle, MA, USA

4. Department of Pediatrics and Genetics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1238538

Reference57 articles.

1. Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

2. Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells.

3. Enhanced Activity of Hu14.18-IL2 Immunocytokine against Murine NXS2 Neuroblastoma when Combined with Interleukin 2 Therapy

4. A recombinant antibody-interleukin 2 fusion protein suppresses growth of hepatic human neuroblastoma metastases in severe combined immunodeficiency mice.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interplay of co-cultured chimeric adipose and gingival tissues exacerbates inflammatory dysfunction relevant to periodontal and metabolic conditions;Life Sciences;2024-10

2. Enhancing in situ cancer vaccines using delivery technologies;Nature Reviews Drug Discovery;2024-07-01

3. Site-specific pegylated IL2 mutein with biased IL2 receptor binding for cancer immunotherapy;International Immunopharmacology;2024-07

4. Cytokine Biopharmaceuticals with “Activity-on-Demand” for Cancer Therapy;Bioconjugate Chemistry;2024-06-17

5. Spatiotemporally programming cytokine immunotherapies through protein engineering;Immunological Reviews;2023-07-06